Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
ACTC--NEWS
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by IMAKEMONEY: [QB] Advanced Cell, Mytogen Extend Letter Of Intent For 15 Days Jul 17, 2007 09:33:28 (ET) Advanced Cell Technology Inc. (ACTC) disclosed Tuesday that it has extended its letter of intent to acquire acquire Mytogen Inc. and its Myoblast program for the treatment of heart failure. According to a filing with the Securities and Exchange Commission, the term of the letter was extended for an additional 15 days. The original deadline for closing the transaction was Tuesday, but the extension gives the parties until July 31. The letter of intent provides for a purchase price of $5 million, payable in common stock, plus the assumption of certain Mytogen liabilities of around $1 million. Mytogen will also receive a warrant to purchase an additional 1.5 million Advanced Cell shares for $1, subject to achievement of certain milestones. The letter is subject to several closing conditions including approvals from the Food and Drug Administration, final intellectual-property due diligence and execution of a definitive agreement. Shares of Advanced Cell Technology closed Monday at 44 cents each. -Chad Clinton, Dow Jones Newswires; 202-862-1349; chad.clinton*dowjones.com (END) Dow Jones Newswires July 17, 2007 09:33 ET (13:33 GMT) [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2